Analyst Ranking
Top 25%
#1292 out of 5223 analysts
Average Return
+5.16%
Win Rate
41%23 out of 56
Risk vs Reward
Poor
Good

Uy Ear's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Arcutis Biotherapeutics IncARQT
+306.12%$3.43$13.93
2024-01-02 -
2024-12-31
Strong Buy
Arcutis Biotherapeutics IncARQT
+272.38%$3.91$14.56
2024-01-02 -
2025-01-02
Strong Buy
Mbx Biosciences IncMBX
+140.00%$11.95$28.68
2025-08-05 -
2026-03-20
Buy
Cabaletta Bio IncCABA
+131.36%$8.10$18.74
2023-03-17 -
2024-03-15
Strong Buy
Arcutis Biotherapeutics IncARQT
+104.31%$13.22$27.01
2025-02-26 -
2026-02-25
Buy

Uy Ear Analyst Color

Get additional color on Uy Ear's coverage of popular stocks

Uy Ear's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Relmada Therapeutics IncRLMD
3Buy$19.00+213.01%Maintains
2 days ago
Sarepta Therapeutics IncSRPT
9Buy$31.00+85.74%Maintains
9 days ago
Uniqure NvQURE
8Buy$35.00+117.53%Upgrades
12 days ago
Arcutis Biotherapeutics IncARQT
15Buy$35.00+57.59%Maintains
21 days ago
Acadia Pharmaceuticals IncACAD
16Buy$35.00+68.76%Upgrades
a month ago
Neurocrine Biosciences IncNBIX
10Hold$175.00+37.06%Maintains
3 months ago
Evolus IncEOLS
4Buy$19.00+309.48%Maintains
4 months ago
Alkermes PLCALKS
6Buy$45.00+59.86%Maintains
5 months ago
Mbx Biosciences IncMBX
2Buy$56.00+95.26%Maintains
6 months ago
Tectonic Therapeutic IncTECX
6Buy$85.00+184.47%Maintains
10 months ago
Sage Therapeutics IncSAGE
2Hold$16.00N/AMaintains
2 years ago
Cartesian Therapeutics IncRNAC
3Strong Buy$40.00N/AInitiates Coverage On
2 years ago
Revance Therapeutics IncRVNC
1Strong Buy$16.00N/AMaintains
2 years ago
Johnson & JohnsonJNJ
1Strong Buy$40.00N/AMaintains
3 years ago
Satsuma Pharmaceuticals IncSTSA
1Hold$2.00N/AReiterates
3 years ago
Cabaletta Bio IncCABA
1Strong Buy$10.00N/AReiterates
3 years ago
Ocugen IncOCGN
2Strong Buy$3.00N/AMaintains
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.